Condition
Gastroesophageal Reflux Disease (GERD) clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Gastroesophageal Reflux Disease (GERD) clinical trials that are recruiting, at sites in 7 countries (most in Italy (2), United States (2), Germany (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 7Countries
Newest Gastroesophageal Reflux Disease (GERD) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| GERD patients: see how symptoms relate to posture, pain, and activity | — | Karabük, Karabük Province | Recruiting | Jun 12, 2026 |
| Afluxin® for adults with gastroesophageal reflux disease (GERD) | — | Genova and 6 other locations | Recruiting | May 22, 2025 |
| Comparing Vonoprazan and Pantoprazole for Treating GERD | Phase 4 | Giza | Recruiting | Aug 21, 2024 |
| Registry to evaluate RefluxStop for treating GERD | — | Friedrichshafen and 5 other locations | Recruiting | May 23, 2023 |
| Registry for gastrointestinal motility disorders at Indiana University | — | Indianapolis, Indiana | Recruiting | Aug 10, 2020 |
| Registry for identifying risk factors of esophageal cancer | — | Pittsburgh, Pennsylvania | Recruiting | Dec 1, 2005 |
All recruiting trials (6)
-
GERD patients: see how symptoms relate to posture, pain, and activity
This study will look at whether people with GERD have different posture, pain levels, and activity compared with what their GERD symptoms suggest.
-
Afluxin® for adults with gastroesophageal reflux disease (GERD)
This trial will test whether Afluxin® reduces heartburn and acid regurgitation in adults with GERD who are not currently using PPIs or other acid-suppressing treatments.
-
Comparing Vonoprazan and Pantoprazole for Treating GERD
This study tests whether a new medication called vonoprazan works better than pantoprazole for treating GERD symptoms in adults aged 17 to 60.
-
Registry to evaluate RefluxStop for treating GERD
This study is testing the RefluxStop device to see if it safely helps people with GERD feel better compared to standard treatments.
-
Registry for gastrointestinal motility disorders at Indiana University
This study is creating a detailed list of patients with gastrointestinal motility disorders to help doctors better understand and treat these conditions.
-
Registry for identifying risk factors of esophageal cancer
This study is trying to find out if certain blood and tissue markers can help identify people at risk for esophageal cancer by looking at their medical history and samples.
Related topics
Quick answers
How many Gastroesophageal Reflux Disease (GERD) clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in Italy (2 trials), United States (2 trials), Germany (1 trial), Norway (1 trial), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.